HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

OTTAWA, Dec. 07, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE:HEXO) announces that it has made an amendment (the “Amendment”) to its notice of meeting dated October 28, 2020 (the “Notice of Meeting”) and its management information circular dated October 28, 2020 (the “Circular”) in respect of its annual and special meeting of shareholders scheduled to be held on December 11, 2020 (the “Meeting”).

HEXO Corp Announces Downward Revision to its Proposed Share Consolidation Ratio

One piece of news is giving investors a splitting headache.

Why HEXO Dived on Friday While Other Marijuana Stocks Soared

Annual General Meeting Scheduled for December 11, 2020 Annual General Meeting Scheduled for December 11, 2020

HEXO Corp to Release Fiscal First Quarter 2021 Financial Results and Host Investor Webcast

HEXO (HEXO) closed at $1.17 in the latest trading session, marking no change from the prior day.

HEXO (HEXO) Flat As Market Sinks: What You Should Know

HEXO stock is a credible play on firmness in the Canadian cannabis market and rising demand for weed drinks. The post With Canada's Cannabis Market Growing, Hexo Merits Attention appeared first on InvestorPlace.

With Canada's Cannabis Market Growing, Hexo Merits Attention

HEXO saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

HEXO Catches Eye: Stock Jumps 9.4%

SNDL Inc.

The path toward legalization took another small step forward today.

Why 3 Small Pot Stocks Are Moving Higher Today

The HEXO stock bears and short sellers were victorious in 2020's first half, but the bulls are now standing firm and might regain control. The post The Beatdown of Hexo Stock May Be Finally Coming to an End appeared first on InvestorPlace.

The Beatdown of Hexo Stock May Be Finally Coming to an End

An announcement on the company's high-end cannabis brand didn't hold investors' interest.

Why Shares of HEXO Shot Up, Then Down, Today

Given the company's poor balance sheet, Hexo stock is not likely to create shareholder value in the coming weeks. The post Why the Pain In Hexo Shares Is Likely to Continue appeared first on InvestorPlace.

Why the Pain In Hexo Shares Is Likely to Continue

Investors in cannabis stocks are remaining alert as shares of HEXO stock have been on the move Tuesday alongside heavy trading. The post Cannabis Stocks Alert: Is HEXO Stock a Buy?

Cannabis Stocks Alert: Is HEXO Stock a Buy?

OTTAWA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to announce that it has repositioned the UP Cannabis (“UP”) brand with a differentiator of 20% THC or higher in all dried flower products, every time. With a focus on consumer feedback, HEXO has launched a bold new campaign to support UP's re-entry to the market and has adapted processes and systems to deliver improvements on quality and freshness, at a fair price. By building trust and credibility with consumers, UP is aiming to become Canada's Cannabis.

UP Cannabis repositions brand and launches bold brand differentiator: 20% THC or higher in all its flower products, every time

Aurora Cannabis

Aphria

Aphria closed on a new acquisition, and general sentiment continues to push pot stocks higher.

Why Aurora Cannabis, Aphria, and HEXO Shares Rose Again Today

According to reports, the Covid 19 pandemic has taken a serious toll on mental health. Such conditions have played right into the hands of cannabis producers such as Hexo (NYSE:HEXO).

Why I Feel Investors Should Go Long With Hexo Stock

OTTAWA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that the Company will participate in the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020. Sebastien St. Louis, Chief Executive Officer, will present in the cannabis panel on Beverages, Beer and Beyond at 8:30 a.m. ET. For further details, please contact your Cowen representative.

HEXO Corp to Participate in the Cowen 2020 Boston Cannabis Conference

HEXO stock is in a good position; with the launch of a new beverage brand, Canada's cannabis market's growth, and soaring revenues. The post As Canadian Cannabis Finds Its Feet, HEXO Stock Has Room to Run appeared first on InvestorPlace.

As Canadian Cannabis Finds Its Feet, HEXO Stock Has Room to Run

Canopy Growth

Cronos Group

Tilray Brands

Cannabis stocks are soaring higher on Tuesday as investors continue to prepare for a Joe Biden presidency that could benefit pot companies. The post Cannabis Stocks: Why ACB, TLRY, CGC, HEXO and CRON Are Soaring Today appeared first on InvestorPlace.

Cannabis Stocks: Why ACB, TLRY, CGC, HEXO and CRON Are Soaring Today

HEXO stock is down more than 50% in 2020. And the company's latest attempt at redefining itself is CBD-infused beverages looks lke a heavy lift.

Hexo Has to Show That This Time Is Different

This divergence between Canadian marijuana sales and cannabis stock performance may continue.

Canada's Weed Sales Just Hit a New High -- Here's Why That Hasn't Helped Pot Stocks

Hexo stock is a losing bet. Hexo stock won't survive without further capital, providing investors a great shorting opportunity.

Hexo Stock Is a Losing Bet So Investors Should Short It

Its shares have been soaring this month -- but will the rally continue?

Is HEXO Stock a Buy?

Arena Pharmaceuticals

FSD Pharma

Akerna Corp

OrganiGram Holdings Inc.

Village Farms International

cbdMD Inc

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in the upcoming week.

11 Cannabis Stocks Making Moves While Riding the 'Green Wave'

Net revenue continues to trend upwards as demand has grown, average price per gram has increased to $2.95 from $2.22 (excluding beverages). Hexo with its subsidiary, Truss, has first mover's advantage with its adult beverages as it becomes a top-selling product.

Hexo: Business Is Improving Albeit Slowly

Why Aurora Cannabis, HEXO, and Tilray Stocks Just Crashed

OTTAWA, Nov. 09, 2020 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is pleased to announce that Trent MacDonald's security clearance request under the Cannabis Act has been granted by Health Canada. As previously announced, Mr. MacDonald had been appointed to the Company's executive leadership team in the acting role of Chief Financial Officer, with his permanent role as Chief Financial Officer to commence upon the successful completion of Health Canada's security clearance process for key personnel. With his security clearance having been granted, Mr. MacDonald now moves into a permanent role as Chief Financial Officer.

News for HEXO Corp Stock (HEXO)